Title of Collaborative Activity: |
FDA/NIH Interagency Clinical Outcomes Assessments Working Group Meeting |
Description of Collaborative Activity: |
The Food and Drug Administration (FDA) and Institute representatives from the National Institutes of Health (NIH) meet periodically to discuss the development of valid patient-oriented treatment outcomes, and relative measurements, for use in clinical trials of therapeutic interventions. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2013 |
NIH Participating Institutes/Centers/Office of the Director: |
NCCIH, NCI, NHLBI, NIAMS, NIMH, NINDS |
HHS Agency Collaborators on this Activity: |
FDA |
